Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using ...

The CDC can now gain the evidence-based data that they have claimed is lacking.

In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days per month versus placebo, consistent with previous trials in ...

At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

The Medtronic investment and the underwritten public offering of common stock position Anteris to continue to execute the global PARADIGM Trial and to continue investing in research that can transform ...

Investigators reported extended 5-year follow-up data from the CheckMate 274 trial including exploratory MIBC and circulating tumor (ct)DNA data.

Hoth Therapeutics has shared phase 2 results on its treatment of EGFR inhibitor-induced skin toxicities, ticking off another ...

Dutch trial establishes feasibility of screening approach in routine specialty care ...

When comparing diet soda vs regular soda, diet soda limits blood sugar spikes, but neither option is ideal for long-term ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across ...

Corvus Pharmaceuticals shares jumped 90.3% to $15.32 on Tuesday. Here are some other big stocks recording gains in today’s ...